AN OPEN-LABEL SAFETY AND PHARMACOKINETIC STUDY OF OLUMACOSTAT GLASARETIL GEL APPLIED UNDER MAXIMUM USE CONDITIONS IN PATIENTS WITH ACNE VULGARIS

Registry ID
DRM01B-ACN06
Source registry
HEALTH_CANADA
Status
Ongoing
Study type
INTERVENTIONAL
Sponsor
DERMIRA INCORPORATED
Start date
2017-12-11
Last update
2017-12-06

Conditions

Related clinical trials

View on source registry